Joaquín Rodrigo, president of BioSim celebrates the 15th anniversary of the first biosimilar in Europe. In a matter of biosimilars, Europe has become a benchmark, being one of the first regions in the world to implement and extend its use to the population. As a result, millions of patients have benefited from access to effective and safe biological therapies thanks to biosimilar medicines.